ReShape Lifesciences Inc. (RSLS)

ReShape Lifesciences Revenue

ReShape Lifesciences had revenue of $8.34M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $1.94M. In the year 2023, ReShape Lifesciences had annual revenue of $8.68M.

• Revenue (ttm): $8.34M
• Revenue Growth: -24.82%
• P/S Ratio: 0.75
• Revenue / Employee: $287,414
• Employees: 29
• Market Cap: 6.21M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	8.68M	-2.56M	-22.79%
Dec 31, 2022	11.24M	-2.36M	-17.35%
Dec 31, 2021	13.60M	2.30M	20.36%
Dec 31, 2020	11.30M	8.02M	244.38%
Dec 31, 2019	3.28M	-5.82M	-63.95%
Dec 31, 2018	9.10M	-813.00K	-8.20%
Dec 31, 2017	9.91M	6.52M	192.19%
Dec 31, 2016	3.39M	-646.00K	-15.99%
Dec 31, 2015	4.04M	500.00K	14.13%
Dec 31, 2014	3.54M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.